These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2138096)

  • 1. Effect of etretinate on peripheral T lymphocytes in psoriatic patients before, during and after 6 months of therapy.
    David M; Shohat B; Hodak E; Sandbank M
    Dermatologica; 1990; 180(2):86-9. PubMed ID: 2138096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of etretinate on the distribution of Langerhans cells and T. lymphocytes in psoriatic skin.
    Ranki A; Lauharanta J; Kanerva L
    Arch Dermatol Res; 1984; 276(2):102-4. PubMed ID: 6609684
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisone-induced alterations of circulating human lymphocyte subsets.
    Slade JD; Hepburn B
    J Lab Clin Med; 1983 Mar; 101(3):479-87. PubMed ID: 6219171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of Ro 10-9359 on lectin-induced activation and proliferation of T lymphocytes.
    Stosić-Grujicić S; Konstantinović S; Simić MM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():203-5. PubMed ID: 2609871
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies.
    Keystone EC; Lau C; Gladman DD; Wilkinson S; Lee P; Shore A
    Clin Exp Immunol; 1982 May; 48(2):443-8. PubMed ID: 6213329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-lymphocyte subpopulations in uveitis.
    Murray PI; Dinning WJ; Rahi AH
    Br J Ophthalmol; 1984 Oct; 68(10):746-9. PubMed ID: 6236843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of lymphocyte subpopulations with monoclonal antibodies in five psoriatic patients treated with etretinate.
    Lazzini C; Trevisan G; de Luyk S; Mangiarotti M
    Ric Clin Lab; 1984; 14(3):323-5. PubMed ID: 6335285
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in T lymphocyte subpopulations associated with renal allograft rejection.
    Stelzer GT; McLeish KR; Lorden RE; Watson SL
    Transplantation; 1984 Mar; 37(3):261-4. PubMed ID: 6230781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
    Chieregato GC; Leoni A
    Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in psoriatic patients.
    Borroni G; Brazzelli V; Fietta A; Gatti M; Bellosta M; Vignati G; Zaccone C; Berardesca E; Rabbiosi G
    Acta Derm Venereol Suppl (Stockh); 1989; 146():125-9. PubMed ID: 2514541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft versus host reaction in the rat: effect of cyclosporin A and cyclophosphamide on lymphocyte subsets involved in GvHR.
    van den Broek AA; Stet RJ; van Eden GG; Kuiper J; Meedendorp B; Thomas C
    Adv Exp Med Biol; 1985; 186():539-44. PubMed ID: 2931960
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of circulating T-lymphocyte subpopulations with monoclonal antibodies in psoriasis].
    Paciel J; Vignale R; Calandria L; Bruno J; Tarallo N
    Med Cutan Ibero Lat Am; 1985; 13(4):341-5. PubMed ID: 2936938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating T-cell subpopulations in lithium-associated granulocytosis.
    Crockard AD; Desai ZR; Ennis KT
    J Immunopharmacol; 1984; 6(3):215-26. PubMed ID: 6238100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
    Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
    Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imbalance of T lymphocyte subpopulations in patients with psoriasis and its immune correction].
    Rubins AJ; Mashkilleysson AL; Merson AG; Gipsh NM
    Z Hautkr; 1987 Mar; 62(6):497-501. PubMed ID: 2954313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
    Charreire J; Karsenty G; Bouchard P; Schaison G
    Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.